Form 8-K - Current report:
SEC Accession No. 0001213900-21-009291
Filing Date
2021-02-16
Accepted
2021-02-16 09:17:57
Documents
59
Period of Report
2021-02-16
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea135617-8k_citiuspharma.htm 8-K 20323
2 CORPORATE PRESENTATION OF FEBRUARY 2021. ea135617ex99-1_citiuspharma.htm EX-99.1 71011
3 PRESS RELEASE, DATED FEBRUARY 16, 2021. ea135617ex99-2_citiuspharma.htm EX-99.2 38866
4 GRAPHIC ex99-1_001.jpg GRAPHIC 108365
5 GRAPHIC ex99-1_002.jpg GRAPHIC 378316
6 GRAPHIC ex99-1_003.jpg GRAPHIC 295256
7 GRAPHIC ex99-1_004.jpg GRAPHIC 270928
8 GRAPHIC ex99-1_005.jpg GRAPHIC 321574
9 GRAPHIC ex99-1_006.jpg GRAPHIC 366380
10 GRAPHIC ex99-1_007.jpg GRAPHIC 260016
11 GRAPHIC ex99-1_008.jpg GRAPHIC 151444
12 GRAPHIC ex99-1_009.jpg GRAPHIC 285313
13 GRAPHIC ex99-1_010.jpg GRAPHIC 186003
14 GRAPHIC ex99-1_011.jpg GRAPHIC 400744
15 GRAPHIC ex99-1_012.jpg GRAPHIC 424095
16 GRAPHIC ex99-1_013.jpg GRAPHIC 397775
17 GRAPHIC ex99-1_014.jpg GRAPHIC 375634
18 GRAPHIC ex99-1_015.jpg GRAPHIC 236478
19 GRAPHIC ex99-1_016.jpg GRAPHIC 242073
20 GRAPHIC ex99-1_017.jpg GRAPHIC 143737
21 GRAPHIC ex99-1_018.jpg GRAPHIC 240365
22 GRAPHIC ex99-1_019.jpg GRAPHIC 317042
23 GRAPHIC ex99-1_020.jpg GRAPHIC 333878
24 GRAPHIC ex99-1_021.jpg GRAPHIC 282040
25 GRAPHIC ex99-1_022.jpg GRAPHIC 297742
26 GRAPHIC ex99-1_023.jpg GRAPHIC 296878
27 GRAPHIC ex99-1_024.jpg GRAPHIC 216440
28 GRAPHIC ex99-1_025.jpg GRAPHIC 252574
29 GRAPHIC ex99-1_026.jpg GRAPHIC 267841
30 GRAPHIC ex99-1_027.jpg GRAPHIC 407097
31 GRAPHIC ex99-1_028.jpg GRAPHIC 277152
32 GRAPHIC ex99-1_029.jpg GRAPHIC 408174
33 GRAPHIC ex99-1_030.jpg GRAPHIC 239022
34 GRAPHIC ex99-1_031.jpg GRAPHIC 255668
35 GRAPHIC ex99-1_032.jpg GRAPHIC 471136
36 GRAPHIC ex99-1_033.jpg GRAPHIC 431558
37 GRAPHIC ex99-1_034.jpg GRAPHIC 891230
38 GRAPHIC ex99-1_035.jpg GRAPHIC 335591
39 GRAPHIC ex99-1_036.jpg GRAPHIC 198303
40 GRAPHIC ex99-1_037.jpg GRAPHIC 424541
41 GRAPHIC ex99-1_038.jpg GRAPHIC 191268
42 GRAPHIC ex99-1_039.jpg GRAPHIC 311991
43 GRAPHIC ex99-1_040.jpg GRAPHIC 360053
44 GRAPHIC ex99-1_041.jpg GRAPHIC 376488
45 GRAPHIC ex99-1_042.jpg GRAPHIC 251124
46 GRAPHIC ex99-1_043.jpg GRAPHIC 175822
47 GRAPHIC ex99-1_044.jpg GRAPHIC 399283
48 GRAPHIC ex99-1_045.jpg GRAPHIC 349544
49 GRAPHIC ex99-1_046.jpg GRAPHIC 230880
50 GRAPHIC ex99-1_047.jpg GRAPHIC 128882
51 GRAPHIC ex99-1_048.jpg GRAPHIC 353490
52 GRAPHIC ex99-1_049.jpg GRAPHIC 217519
53 GRAPHIC ex99-1_050.jpg GRAPHIC 181321
54 GRAPHIC ex99-1_051.jpg GRAPHIC 241346
55 GRAPHIC ex99-1_052.jpg GRAPHIC 230968
56 GRAPHIC ex99-1_053.jpg GRAPHIC 129970
57 GRAPHIC ex99-2_001.jpg GRAPHIC 10453
58 GRAPHIC ex99-2_002.jpg GRAPHIC 101040
59 GRAPHIC ex99-2_003.jpg GRAPHIC 55559
  Complete submission text file 0001213900-21-009291.txt   21298956
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 21633234
SIC: 2834 Pharmaceutical Preparations